Blog

Nihil enim qui mollitia

October 6, 2024

Ipsa velit itaque expedita qui asperiores. Facere et occaecati dolores Quisquam laudantium recusandae alias nobis. Error aut perferendis voluptatem

Subjective Sexual Response to Testosterone Replacement Therapy Based on Initial Serum Levels of Total Testosterone

Occult Prostate Cancer in Men With Low Serum Testosterone Levels

Prevalence Of Prostate Cancer Among Hypogonadal Men With Prostate-specific Antigen Levels Of 4.0 Ng/ml Or Less

High Rates of Depression and Depressive Symptoms among Men Referred for Borderline Testosterone Levels

A Harvard expert shares his thoughts on testosterone replacement therapy

Appropriate testosterone testing for male hypogonadism

Canadian Urological Association guideline on testosterone deficiency in men: Evidence-based Q&A

Appropriate testosterone testing for male hypogonadism

Daily subcutaneous testosterone for management of testosterone deficiency

Lessons From The Testosterone Trials PMC

Testosterone Therapy With Subcutaneous Injections A Safe Practical And Reasonable Option PMC

Testosterone Replacement Therapy

Testosterone and the aging male: To treat or not to treat?

REPORT: Canadian Society for the Study of the Aging Male: Response to Health Canada's Position Paper on Testosterone Treatment

Our Philosophy: Health Soverignty

Results and What to Expect

Hormone Optimization Package

Men's Longevity Package

Men's Health Sovereignty Package

Speciality Services

Navigation

Services

Contact

[email protected]

[email protected]

(239) 555-0108

Vancouver, BC

Stay informed by subscribing to our newsletter.

© 2025 – All Rights Reserved.